These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37436574)

  • 61. Association of C4d deposition with clinical outcomes in IgA nephropathy.
    Espinosa M; Ortega R; Sánchez M; Segarra A; Salcedo MT; González F; Camacho R; Valdivia MA; Cabrera R; López K; Pinedo F; Gutierrez E; Valera A; Leon M; Cobo MA; Rodriguez R; Ballarín J; Arce Y; García B; Muñoz MD; Praga M;
    Clin J Am Soc Nephrol; 2014 May; 9(5):897-904. PubMed ID: 24578331
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
    Mizerska-Wasiak M; Małdyk J; Pańczyk-Tomaszewska M; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Miklaszewska M; Pietrzyk J; Pukajło-Marczyk ; Zwolińska D; Szczepańska M; Demkow U; Roszkowska-Blaim M
    Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
    Bellur SS; Roberts ISD; Troyanov S; Royal V; Coppo R; Cook HT; Cattran D; Arce Terroba Y; Asunis AM; Bajema I; Bertoni E; Bruijn JA; Cannata-Ortiz P; Casartelli D; Maria Di Palma A; Ferrario F; Fortunato M; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Giannakakis K; Gomà M; Gröne HJ; Gutiérrez E; Asma Haider S; Honsova E; Ioachim E; Karkoszka H; Kipgen D; Maldyk J; Mazzucco G; Orhan D; Ozluk Y; Pantzaki A; Perkowska-Ptasinska A; Riispere Z; Soderberg MP; Steenbergen E; Stoppacciaro A; Sundelin Von Feilitzen B; Tardanico R
    Nephrol Dial Transplant; 2019 Oct; 34(10):1681-1690. PubMed ID: 30561721
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Validation of the Oxford classification of IgA nephropathy.
    Herzenberg AM; Fogo AB; Reich HN; Troyanov S; Bavbek N; Massat AE; Hunley TE; Hladunewich MA; Julian BA; Fervenza FC; Cattran DC
    Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study.
    Mima A
    Sci Rep; 2022 Oct; 12(1):17630. PubMed ID: 36271110
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
    Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy.
    Liu LL; Liu N; Chen Y; Wang LN; Jiang Y; Wang J; Li XL; Yao L; Fan QL
    Clin Exp Immunol; 2013 Oct; 174(1):152-60. PubMed ID: 23750697
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.
    Tsushima H; Samejima KI; Eriguchi M; Uemura T; Tasaki H; Fukata F; Nishimoto M; Kosugi T; Tanabe K; Okamoto K; Matsui M; Tsuruya K
    Clin Exp Nephrol; 2022 Aug; 26(8):797-807. PubMed ID: 35426595
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stratifying risk for progression in IgA nephropathy: how to predict the future?
    Rafalska A; Franczuk J; Franczuk P; Augustyniak-Bartosik H; Krajewska M
    Pol Arch Med Wewn; 2014; 124(7-8):365-72. PubMed ID: 24824600
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of alpha5beta1 and alpha6beta1 integrins in IgA nephropathy (IgAN) with mild and severe proteinuria. An immunohistochemical study.
    Wagrowska-Danilewicz M; Danilewicz M
    Int Urol Nephrol; 2004; 36(1):81-7. PubMed ID: 15338682
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Upregulated Expression of Intestinal Antimicrobial Peptide HD5 Associated with Renal Function in IgA Nephropathy.
    Feng S; Zhong Z; Fan J; Li X; Shi D; Jiang L
    Dis Markers; 2020; 2020():2078279. PubMed ID: 32089753
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy.
    Bharti N; Agrawal V; Kamthan S; Prasad N; Agarwal V
    Int Urol Nephrol; 2023 Jun; 55(6):1557-1564. PubMed ID: 36648741
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
    Li G; Wu W; Zhang X; Huang Y; Wen Y; Li X; Gao R
    BMC Nephrol; 2018 Nov; 19(1):326. PubMed ID: 30428849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Crescentic IgA nephropathy in children.
    Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Validation of Oxford Classification of Immunoglobulin A Nephropathy: an Iranian Experience.
    Sadeghipour A; Hendi A; Asgari M; Sotoudeh M; Parvin M; Filip I; Radfar A; Babaheidarian P
    Iran J Kidney Dis; 2016 Jan; 10(1):17-21. PubMed ID: 26837676
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased Tim-3
    Hou J; Zhang L; Wu H; Gao P; Xu Z
    Int Immunopharmacol; 2021 Aug; 97():107666. PubMed ID: 34058623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.